Ticker brief
ENTX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
3
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-06-23 · now +0.25 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OzmosiHealth | C | · | 2 | +0.33 |
| @BiopharmIQ | B | · | 2 | +0.40 |
| @Bezel4455 | C | -2.52 | 1 | +0.45 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-23 | @OzmosiHealth | +0.15 | Entera Bio will present Phase 3 osteoporosis results in 2H28 for EB-613. | · | tweet ↗ |
| 2026-06-23 | @BiopharmIQ | +0.35 | Biotech stock moves list with percentage changes and key company news. | · | tweet ↗ |
| 2026-06-22 | @BiopharmIQ | +0.45 | Biotech stock moves list with percentage changes and associated clinical/regulatory headlines. | · | tweet ↗ |
| 2026-06-22 | @Bezel4455 | +0.45 | ENTX is up 36% with biotech momentum and recent ENDO presentation attention. | · | tweet ↗ |
| 2026-06-22 | @OzmosiHealth | +0.50 | Entera Bio received positive FDA feedback for EB613 Phase 3 study. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.